The fall COVID-19 vaccine season is starting slowly for Pfizer, with U.S. sales of its Comirnaty shots sinking 25% after ...
Pfizer (PFE) exceeded Street forecasts with its Q3 2025 results on Tuesday, thanks mainly to sales from its COVID vaccine ...
By now, you know that the COVID-19 vaccine is the best way to protect against severe COVID infections and reduce your chances of developing long COVID. You also know that the COVID-19 vaccine may have ...
Shares of Pfizer Inc. gave up ground in early Tuesday trading, after the drug giant reported a decline in revenue, as ...
Despite hopes raised by Pfizer's COVID-19 vaccine, it will take huge efforts for India to defeat the coronavirus, with its ...
The Pfizer Covid vaccine increased the risk of heart problems for children sixfold in the first week of having the jab but led to fewer cases in the long term, research suggests.
Some of the rooms in Korea Superfreeze Inc's coldest warehouse are so frigid that a cup of warm water thrown into one will ...
WASHINGTON — The release of COVID-19 vaccine results after the 2020 election may have not been a “coincidence” — and could have been part of an effort by senior Pfizer executives to “deliberately slow ...
Drugmaker Pfizer said Friday that as government contracts come to an end, possibly by early next year, its COVID-19 vaccine will be sold for $110 to $130 per dose. This price model comes down to ...
Pfizer announced Friday that it would submit a request to the FDA Friday for its COVID-19 vaccine to be granted Emergency Use Authorization. Earlier this week, Pfizer said that a final analysis of ...
Moderna lowered the top end of its 2025 revenue forecast by $200 million on Thursday, citing weaker-than-expected sales of ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback